Protect Your Metabolic Health: A Wake-Up Call
Discover why safeguarding your metabolic health is crucial for your overall well-being and brain health. Learn how taking action now can shape a healthier future.
ANTI-AGEINGFATTY LIVER DISEASECARDIOVASCULAR HEALTHCANCERLONGEVITYMETABOLIC HEALTHTYPE 2 DIABETESBRAIN HEALTHINFLAMMATIONBONE HEALTHMUSCLE HEALTHCELLULAR HEALTH
AlexanderJ
11/14/202515 min read
The news that emerged from the Australian Bureau of Statistics in November 2024 sent shockwaves through the health community: dementia, including Alzheimer's disease, is now Australia's leading cause of death, accounting for 9.4% of all deaths, over 17,500 Australians in 2024 alone. Deaths from dementia have surged 39% over the past decade, overtaking ischaemic heart disease for the first time in our nation's history.
For those over 75, dementia is now responsible for a staggering proportion of mortality. The median age of death from dementia is 88.7 years and 62.4% of those who died were women. Without significant intervention, the number of Australians living with dementia is projected to exceed one million by 2065.
But here's the crucial message buried beneath these sobering statistics, up to 45% of dementia cases globally could be prevented or delayed by addressing modifiable risk factors and one of the most significant yet underappreciated of these factors is metabolic syndrome.
The Hidden Connection - Metabolic Syndrome and Dementia
While most people understand that poor diet, lack of exercise, and obesity increase the risk of heart disease and diabetes, far fewer recognise that metabolic dysfunction is systematically destroying brain health, often decades before the first signs of cognitive decline appear.
Metabolic syndrome, a cluster of conditions including abdominal obesity, high blood pressure, elevated blood sugar, high triglycerides and low HDL cholesterol, affects approximately 30-35% of Australian adults, with prevalence surging dramatically after age 45. In fact, more than 35% of Australian adults currently have metabolic syndrome and this figure is even higher among those with existing diabetes or mental health conditions.
The relationship between metabolic syndrome and dementia is not coincidental, it's causal. Here's what the science tells us:
The Metabolic-Dementia Pathway
Multiple large-scale studies have now established that metabolic syndrome substantially increases dementia risk through several interconnected mechanisms:
1. Brain Insulin Resistance
The brain requires insulin for learning, memory formation and neuronal survival. When peripheral metabolic syndrome develops, it induces insulin resistance in the brain, a state some researchers now call "type 3 diabetes." This disrupted insulin signalling makes neurons vulnerable to metabolic stress, accelerates neuronal dysfunction and directly promotes the accumulation of toxic amyloid-beta plaques and tau tangles, the hallmark pathologies of Alzheimer's disease.
Brain regions with the highest density of insulin receptors, particularly the hippocampus and temporal lobe, are also the primary targets of neurodegeneration in Alzheimer's disease. When insulin signalling fails in these regions, memory and cognitive function deteriorate rapidly.
2. Chronic Inflammation and Oxidative Stress
Metabolic syndrome triggers a state of chronic low-grade inflammation throughout the body and brain. Elevated levels of pro-inflammatory cytokines like IL-6, TNF-α, and C-reactive protein damage blood vessels, disrupt the blood-brain barrier, and promote neuroinflammation, all of which accelerate cognitive decline and dementia.
Oxidative stress, an imbalance between damaging free radicals and protective antioxidants, compounds this damage by attacking neurons, mitochondria and DNA, further accelerating brain ageing.
3. Vascular Damage
High blood pressure, elevated cholesterol and diabetes damage cerebral blood vessels, reducing blood flow to the brain and causing white matter lesions, brain injuries visible on MRI scans that are strongly linked to stroke and dementia risk. Metabolic syndrome increases stroke risk by an astounding 195-295%.
4. The Critical Window: Midlife Matters Most
Groundbreaking research published in The Lancet reveals that the timing of metabolic syndrome onset is crucial. Individuals who develop metabolic syndrome in midlife (ages 45-65) face the highest dementia risk, with exposure duration playing a critical role. The longer someone lives with untreated metabolic dysfunction, the greater the cumulative brain damage.
Importantly, those who develop metabolic syndrome before age 45 face prolonged exposure to these metabolic insults during a critical window of brain vulnerability, substantially increasing their lifetime dementia risk.
The Stark Reality - Metabolic Syndrome Increases Your Risk
Studies consistently demonstrate that metabolic syndrome increases the risk of:
Dementia by 33-65%
Alzheimer's disease by 40-60%
Cognitive impairment and faster cognitive decline
Brain atrophy and cortical thinning
Even more concerning, the presence of multiple metabolic syndrome components compounds risk. Individuals with three or more metabolic risk factors face the steepest cognitive decline trajectories.
The Opportunity - Prevention Before It's Too Late
Here's the empowering truth that emerges from this research: metabolic syndrome is reversible, and early intervention can dramatically reduce dementia risk.
The 2024 Lancet Commission on dementia prevention identified 14 modifiable risk factors, including high cholesterol, diabetes, obesity, physical inactivity and hypertension (all components or consequences of metabolic syndrome), that collectively account for 45% of all dementia cases. This means that nearly half of dementia cases could be prevented or delayed through lifestyle and metabolic interventions.
Why Act Now, Before Metabolic Syndrome Develops
The most critical message for anyone over 45 is this: prevention must begin before metabolic syndrome fully develops. Once chronic metabolic dysfunction becomes entrenched, the cumulative damage to the brain, heart, liver and vasculature accelerates exponentially.
Early intervention, addressing elevated blood sugar, cholesterol, blood pressure and abdominal obesity at the first signs can:
Prevent progression to full metabolic syndrome
Reduce dementia risk by 40-50%
Preserve brain structure and cognitive function
Extend healthspan and quality of life.
The Diabetes Prevention Program, one of the most influential lifestyle intervention trials ever conducted, demonstrated that intensive lifestyle changes reduced diabetes incidence by 58% at three years and this protection persisted for 21 years, preventing thousands of cases of diabetes, heart disease and likely dementia.
Even modest interventions produce measurable benefits. A 5-10% reduction in body weight significantly improves metabolic markers, while Mediterranean-style diets, regular physical activity (150 minutes weekly) and targeted nutritional interventions all reduce dementia risk.
The Natural Solution -Tocotrienols and Geranylgeraniol for Metabolic and Brain Protection
While lifestyle interventions form the foundation of metabolic health, emerging clinical evidence demonstrates that specific natural compounds, particularly annatto-derived tocotrienol and geranylgeraniol, provide powerful, multi-targeted protection against the metabolic dysfunction driving dementia risk.
Tocotrienols - Superior Neuroprotection Backed by Science
Tocotrienols represent the most potent and bioavailable form of vitamin E, with a unique molecular structure that allows them to penetrate cell membranes 40-60 times more efficiently than traditional tocopherols. Their neuroprotective potency is extraordinary, tocotrienols are 1,000 times more effective at protecting neurons than alpha-tocopherol.
Clinical Evidence for Metabolic Health:
Multiple human trials demonstrate that annatto tocotrienol supplementation:
Improves glucose homeostasis and insulin sensitivity comparable to metformin
Reduces inflammatory markers including C-reactive protein by 20-50%
Lowers total cholesterol by 15%, LDL by 18%, and triglycerides by 13-28%
Reduces body weight (average 10-15 pounds over 12-24 weeks) and waist circumference
Improves liver health in non-alcoholic fatty liver disease (NAFLD), reducing liver enzymes and hepatic steatosis.
Neuroprotective Benefits:
The neuroprotective effects of tocotrienols are remarkable and extensively documented:
Cross the blood-brain barrier and accumulate in brain tissue even in aged animals with compromised barriers
Reduce oxidative stress by acting as potent free-radical scavengers and promoting mitochondrial function
Prevent glutamate-induced neurotoxicity, a major mechanism of neuronal death
Reduce neuroinflammation and inhibit pro-inflammatory pathways
Protect against stroke-induced brain damage and attenuate white matter lesion progression
Improve spatial learning, memory, and cognitive function in both healthy and cognitively impaired subjects
Reduce beta-amyloid deposition and alter gene expression related to Alzheimer's disease in transgenic AD models
Protect and lengthen telomeres, reversing cellular ageing.
A landmark 2025 human trial published in Frontiers in Nutrition demonstrated that 100mg daily tocotrienol supplementation for 12 weeks significantly improved general memory and non-verbal memory in adults with subjective memory complaints, while also reducing sleep disturbances and inflammation markers.
Geranylgeraniol - Optimising Metabolic Pathways and Mitochondrial Function
Geranylgeraniol (GG) is a critical intermediate in the mevalonate pathway, the biochemical system that produces CoQ10, cholesterol, vitamin K2, and prenylated proteins essential for cellular signalling.
Metabolic and Cognitive Benefits:
Enhances mitochondrial function, boosting ATP production and cellular energy
Improves glucose tolerance and insulin sensitivity in metabolic syndrome models
Reduces inflammation and oxidative stress by lowering IL-6, TNF-α, and CRP
Supports protein prenylation, enabling over 300 human proteins critical for cell signalling, synaptic plasticity, and memory to function properly
Protects muscle mitochondrial quality in diabetes, preventing muscle loss and metabolic decline.
The combination of tocotrienol and geranylgeraniol in a 2:1 ratio provides synergistic protection, tocotrienol's antioxidant and anti-inflammatory power combined with GG's mitochondrial support and metabolic pathway optimisation creates comprehensive cellular defence against metabolic dysfunction.
Safe, Evidence-Based Dosing
Both compounds have exemplary safety profiles:
Tocotrienol: Safe at 600-900mg daily in long-term trials (up to 24 months); FDA GRAS status
Geranylgeraniol: Well-tolerated at 150-300mg daily.
Recommended daily dosing for metabolic health protection:
Prevention/general health (ages 45+): 150-300mg tocotrienol + 75-150mg GG
Mild metabolic concerns: 300-450mg tocotrienol + 150-225mg GG
Active metabolic syndrome: 450-600mg tocotrienol + 225-300mg GG (split across meals).
Always take with meals for optimal absorption (2-3 fold improvement), and do not exceed 300mg tocotrienol per single dose as evidence suggests that higher doses do not equate to greater benefit.
Take Action Today - Your Brain's Future Depends on Your Metabolic Health Now
The connection between metabolic health and dementia is no longer theoretical, it's established scientific fact. As dementia continues to claim more Australian lives than any other condition, the imperative to act has never been clearer.
You have a choice. You can wait until metabolic syndrome develops, until cognitive symptoms appear, until irreversible brain damage accumulates. Or you can act now, protecting your metabolic health before it's too late.
Your Action Plan
1. Know Your Numbers
Schedule comprehensive metabolic screening to assess:
Fasting glucose and HbA1c
Lipid panel (cholesterol, triglycerides, HDL)
Blood pressure
Waist circumference
Inflammatory markers (hs-CRP).
2. Implement Lifestyle Foundations
Adopt a Mediterranean or MIND diet rich in vegetables, fish, nuts, and healthy fats
Exercise 150+ minutes weekly: combine aerobic activity with resistance training
Achieve and maintain healthy weight: even 5-10% weight loss dramatically improves metabolic markers
Prioritise sleep, manage stress, maintain social connections.
3. Consider Evidence-Based Supplementation
For adults over 45, particularly those with early metabolic concerns or family history of dementia or metabolic disease:
Annatto tocotrienol (150-600mg daily) for comprehensive metabolic, cardiovascular and neuroprotective benefits
Geranylgeraniol (75-300mg daily) for mitochondrial support and metabolic optimisation
Optimal 2:1 ratio of tocotrienol to GG.
4. Monitor and Adjust
Track metabolic biomarkers every 3-6 months. Expect measurable improvements in glucose, lipids, inflammatory markers, blood pressure and body composition within 3-6 months of consistent intervention.
The Bottom Line - Prevention Starts Before Disease
The dementia crisis unfolding in Australia is not inevitable. The metabolic dysfunction driving much of this epidemic is preventable, reversible and critically, addressable right now before irreversible damage occurs.
45% of dementia cases are preventable. That's nearly half. For many Australians reading this today, that means the difference between cognitive vitality and dementia is determined by the choices you make about your metabolic health, starting now.
The research is unequivocal: protecting your metabolic health through midlife and beyond is the single most powerful strategy for preserving your brain, your independence and your quality of life for decades to come.
Don't wait for metabolic syndrome. Don't wait for cognitive symptoms. Don't wait for a dementia diagnosis.
Act today. Protect your metabolic health. Protect your brain. Protect your future.
References
Dementia Australia. (2025). Dementia confirmed as Australia's leading cause of death, ABS data reveals.
URL: https://www.dementia.org.au/media-releases/dementia-confirmed-australias-leading-cause-death-abs-data-revealsAustralian Bureau of Statistics. (2025). Dementia is Australia's leading cause of death.
URL: https://www.abs.gov.au/media-centre/media-releases/dementia-australias-leading-cause-deathAustralian Bureau of Statistics. (2025). Causes of Death, Australia, 2024.
URL: https://www.abs.gov.au/statistics/health/causes-death/causes-death-australia/2024Livingston, G., et al. (2024). Dementia prevention, intervention, and care 2024. The Lancet, 404, 10452.
URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01296-0/fulltextBeeri, M.S., & Bendlin, B.B. (2024). Midlife matters: metabolic syndrome and the risk of dementia. The Lancet Healthy Longevity, 5(12).
URL: https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00221-1/fulltextAlzheimer's Research UK. (2024). Addressing 14 health and lifestyle factors could prevent nearly half of global dementia cases.
URL: https://www.alzheimersresearchuk.org/dementia-information/risk-factors-and-prevention/Cameron, A.J., et al. (2007). The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Research and Clinical Practice, 77(3), 471-478.
URL: https://pubmed.ncbi.nlm.nih.gov/17306411/Better Health Victoria. (2025). Metabolic syndrome.
URL: https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/metabolic-syndromeJohn, A.P., et al. (2009). Prevalence of metabolic syndrome among Australians with severe mental illness. Medical Journal of Australia, 190(4), 176-179.
URL: https://www.mja.com.au/journal/2009/190/4/prevalence-metabolic-syndrome-among-australians-severe-mental-illnessQureshi, D., et al. (2024). Role of age and exposure duration in the association between metabolic syndrome and dementia. The Lancet Healthy Longevity, 5(12).
URL: https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00193-X/fulltextKim, B., & Feldman, E.L. (2015). Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Experimental & Molecular Medicine, 47, e149.
URL: https://www.nature.com/articles/emm201551Alzarea, E.A., et al. (2025). The Conceivable Role of Metabolic Syndrome in the Pathogenesis of Alzheimer's Disease. Current Pharmaceutical Design.
URL: https://pubmed.ncbi.nlm.nih.gov/38979771/Lu, R., et al. (2021). Insulin resistance accounts for metabolic syndrome-related alterations in brain structure. Human Brain Mapping, 42(9), 2434-2444.
URL: https://pubmed.ncbi.nlm.nih.gov/33780131/Kullmann, S., et al. (2016). Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiological Reviews, 96(4), 1169-1209.
URL: https://journals.physiology.org/doi/full/10.1152/physrev.00032.2015Frisardi, V., et al. (2010). Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? Journal of Alzheimer's Disease, 21(1), 57-63.
URL: https://pubmed.ncbi.nlm.nih.gov/20182034/Hu, Z., et al. (2020). Shared causal paths underlying Alzheimer's dementia and Type 2 Diabetes. Scientific Reports, 10, 3775.
URL: https://www.nature.com/articles/s41598-020-60682-3Ismail, M., et al. (2020). Safety and neuroprotective efficacy of palm oil and tocotrienol-rich fraction from palm oil: A systematic review. Nutritional Neuroscience, 23(7), 555-573.
URL: https://pubmed.ncbi.nlm.nih.gov/30380987/Razay, G., et al. (2007). The metabolic syndrome and Alzheimer disease. Archives of Neurology, 64(1), 93-96.
URL: https://pubmed.ncbi.nlm.nih.gov/17210814/Chin, K.Y., & Ima-Nirwana, S. (2018). A review on the relationship between tocotrienol and Alzheimer disease. Nutrients, 10(7), 881.
URL: https://www.mdpi.com/2072-6643/10/7/881Sen, C.K., et al. (2006). Tocotrienols: Vitamin E Beyond Tocopherols. Life Sciences, 78(18), 2088-2098.
URL: https://pubmed.ncbi.nlm.nih.gov/16458936/Ibrahim, N., et al. (2014). Clinical investigation of the protective effects of palm tocotrienol on brain white matter lesions. Stroke, 45(5), 1422-1428.
URL: https://pubmed.ncbi.nlm.nih.gov/24699052/Digital Teknoscienze. (2024). Tocotrienols for brain health and cognitive support.
URL: https://digital.teknoscienze.com/nutra-foods/march-2024/tocotrienols-for-brain-health-and-cognitive-supportYu, J., et al. (2025). Changes of metabolic syndrome status alter the risks of stroke and all-cause mortality. Nature Communications.
URL: https://www.nature.com/articles/s41467-025-45678-9Qureshi, D., et al. (2024). Role of age and exposure duration in the association between metabolic syndrome and dementia. The Lancet Healthy Longevity, 5(12).
URL: https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00193-X/fulltextBeeri, M.S., & Bendlin, B.B. (2024). Midlife matters: metabolic syndrome and the risk of dementia. The Lancet Healthy Longevity, 5(12).
URL: https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00221-1/fulltextYue, C., et al. (2024). Association between Alzheimer's disease and metabolic syndrome: insights into the role of dyslipidemia. Biomedicine & Pharmacotherapy.
URL: https://www.sciencedirect.com/science/article/pii/S0753332224000010Chen, W., et al. (2025). Associations of metabolic syndrome with risks of dementia and cognitive impairment. Aging and Disease.
URL: https://journals.sagepub.com/doi/10.1177/26331055241272648Panza, F., et al. (2010). Metabolic syndrome and cognition in healthy aging. American Journal of Clinical Nutrition, 91(4), 831-840.
URL: https://pubmed.ncbi.nlm.nih.gov/20181812/Chen, W., et al. (2024). Associations of metabolic syndrome with risks of dementia and cognitive impairment. Aging and Disease.
URL: https://journals.sagepub.com/doi/10.1177/26331055241272648Alzarea, E.A., et al. (2025). The Conceivable Role of Metabolic Syndrome in the Pathogenesis of Alzheimer's Disease. Current Pharmaceutical Design.
URL: https://pubmed.ncbi.nlm.nih.gov/38979771/Neurology.org. (2024). Association Between Metabolic Syndrome and Young-onset Dementia.
URL: https://www.neurology.org/doi/10.1212/WNL.0000000000209935Hu, Z., et al. (2020). Shared causal paths underlying Alzheimer's dementia and Type 2 Diabetes. Scientific Reports, 10, 3775.
URL: https://www.nature.com/articles/s41598-020-60682-3Lu, R., et al. (2021). Insulin resistance accounts for metabolic syndrome-related alterations in brain structure. Human Brain Mapping, 42(9), 2434-2444.
URL: https://pubmed.ncbi.nlm.nih.gov/33780131/Chen, W., et al. (2025). Expanding the understanding of insulin resistance in brain and metabolic disease. Metabolic Brain Disease.
URL: https://www.sciencedirect.com/science/article/pii/S0889159124000012Cameron, A.J., et al. (2024). Association of the age of onset of metabolic syndrome with cardiovascular disease. Journal of the American Heart Association.
URL: https://www.sciencedirect.com/science/article/pii/S0002934324003796Handelsman, Y., et al. (2023). Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases. Journal of Diabetes and its Complications, 37(1), 108389.
URL: https://www.sciencedirect.com/science/article/pii/S1056872722002385Carris, N.W., et al. (2023). A systematic approach to treating early metabolic disease. Diabetes Therapy, 9(4), 1497-1518.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399894/Queensland Specialist Weight Loss Centre. (2025). Metabolic Syndrome: A Silent Health Risk.
URL: https://qsweightloss.com.au/metabolic-syndrome/Livingston, G., et al. (2024). Dementia prevention, intervention, and care 2024. The Lancet, 404, 10452.
URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01296-0/fulltextJohnstone, A.M., et al. (2025). Consensus statement on exploring the Nexus between nutrition and brain health. Nutrition Bulletin.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11329611/Mitohealth. (2025). A Deep Dive into Improving Metabolic Health and Longevity.
URL: https://mitohealth.com/blog/metabolic-health-and-longevityKnowler, W.C., et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393-403.
URL: https://www.nejm.org/doi/full/10.1056/NEJMoa012512Healthdirect Australia. (2025). Metabolic syndrome.
URL: https://www.healthdirect.gov.au/metabolic-syndromeTownsend, R., et al. (2024). Nutrition for dementia prevention: a state of the art update for clinicians. Age and Ageing, 53(5).
URL: https://www.research.ed.ac.uk/en/publications/nutrition-for-dementia-prevention-a-state-of-the-art-update-for-c/Castro, C.B., et al. (2023). Multi-domain interventions for dementia prevention—a systematic review. FJ Nutr Health Aging..
URL: https://pubmed.ncbi.nlm.nih.gov/38151879/Dalle Grave, R., et al. (2010). Lifestyle modification in the management of the metabolic syndrome. Diabetes, Metabolic Syndrome and Obesity, 3, 373-385.
URL: https://pubmed.ncbi.nlm.nih.gov/21437107/Nardev Ramanathan, et al. (2018). Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities. NIH PMC.
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5775572/Nutraceutical Business Review. (2025). New scientific reviews highlight tocotrienols' potent neuroprotection.
URL: https://nutraceuticalbusinessreview.com/new-scientific-reviews-highlight-tocotrienols-potent-neuroprotective-effectsChwan-Li Shen., et al. (2018). Annatto-extracted tocotrienols improve glucose homeostasis and chronic inflammation in diet-induced obese mice. Scientific Reports, 8, 10470.
URL: https://www.nature.com/articles/s41598-018-29063-9Eunhee Chung., et al. (2021). Beneficial effect of dietary geranylgeraniol on glucose homeostasis and skeletal muscle in high-fat diet-fed mice. Nutr Res.
URL: https://pubmed.ncbi.nlm.nih.gov/34352722/Kok-Lun Pang. et al. (2019). The Role of Tocotrienol in Protecting Against Metabolic Diseases. Molecules, 24(5), 923.
URL: https://pubmed.ncbi.nlm.nih.gov/30845769/Ban-Hock Khor., et al. (2021). Effects of tocotrienols supplementation on markers of inflammation: A systematic review and meta-analysis of randomized controlled trials. PLoS One.
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8301652/Chwan-Li Shen., et al. (2021). Dietary annatto-extracted tocotrienol reduces inflammation and oxidative stress in obese mice. Nutrients.
URL: https://pubmed.ncbi.nlm.nih.gov/33924335/Nutraceutical Business Review. (2024). Tocotrienol for cardiovascular health: the superior vitamin E form
URL: https://nutraceuticalbusinessreview.com/tocotrienol-cardiovascular-health-vitamin-E-heart-healthKailash Prasad. (2011). Tocotrienols and cardiovascular health. PubMed.
URL: https://pubmed.ncbi.nlm.nih.gov/21774782/Muhammad Amjad Pervez., et al. (2018). Effects of delta-tocotrienol supplementation on liver enzymes, inflammation, oxidative stress and hepatic steatosis in patients with nonalcoholic fatty liver disease PMC.
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6284694/American River Nutrition. (2022). Annatto Tocotrienol Improves Fatty Liver and Hepatic Steatosis.
URL: https://www.americanrivernutrition.com/annatto-tocotrienol-improves-fatty-liver-and-hepatic-steatosis/Kok-Yong Chin., et al. (2023). Tocotrienol in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review. PMC.
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC9965814/Muhammad Amjad Pervez, et al. (2018). Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease. Turk J Gastroenterol.
URL: https://pubmed.ncbi.nlm.nih.gov/29749323/Tocotrienol.org. (2016). Brain Health / Neuroprotection.
URL: https://tocotrienol.org/brain-health-neuroprotection/Sen, C.K., et al. (2004). Tocotrienol: the natural vitamin E to defend the nervous system? Annals of the New York Academy of Sciences, 1031, 127-142.
URL: https://pubmed.ncbi.nlm.nih.gov/15753140/Ismail, M., et al. (2020). Safety and neuroprotective efficacy of palm oil and tocotrienol-rich fraction from palm oil: A systematic review. PubMed..
URL: https://pubmed.ncbi.nlm.nih.gov/32085610/Frank, J., & Chin, K.Y. (2012). Do tocotrienols have potential as neuroprotective dietary factors? Ageing Research Reviews, 11(1), 163-180.
URL: https://pubmed.ncbi.nlm.nih.gov/21763788/Research.monash.edu. (2022). Tocotrienols: Mother Nature's Gift to the Brain.
URL: https://research.monash.edu/en/publications/tocotrienols-mother-natures-gift-to-the-brainChin, K.Y., & Ima-Nirwana, S. (2018). A review on the relationship between tocotrienol and Alzheimer disease. Nutrients, 10(7), 881.
URL: https://www.mdpi.com/2072-6643/10/7/881Ismail, M., et al. (2020). Safety and neuroprotective efficacy of palm oil and tocotrienol-rich fraction from palm oil: A systematic review. Nutrients.
URL: https://pubmed.ncbi.nlm.nih.gov/32085610/Yogheswaran Gopalan., et al. (2014). Clinical investigation of the protective effects of palm vitamin E tocotrienols on brain white matter. Stroke, 45(5), 1422-1428.
URL: https://pubmed.ncbi.nlm.nih.gov/24699052/Mangialasche, F., et al. (2012). Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiology of Aging, 33(10), 2282-2290.
URL: https://www.sciencedirect.com/science/article/abs/pii/S0197458011004982Adrian L. Lopresti, et al. (2025). An examination into the effects of tocotrienols (TheraPrimE® rice) on cognitive abilities and sleep in healthy adults: a randomised, double-blind, placebo-controlled trial. Frontiers in Nutrition, 12.
URL: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1621516/fullNaomi, R., et al. (2021). An Interactive Review on the Role of Tocotrienols in Neurodegenerative Disorders. Frontiers in Cellular Neuroscience, 15.
URL: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2021.754086/fullMakpol, S., et al. (2010). γ-Tocotrienol prevents oxidative stress-induced telomere shortening in human fibroblasts. JOxid Med Cell Longev.
URL: https://pubmed.ncbi.nlm.nih.gov/20716926/Makpol, S., et al. (2011). Tocotrienol-Rich Fraction Prevents Cell Cycle Arrest and Elongates Telomere Length in Senescent Human Diploid Fibroblasts. Journal of Biomedicine and Biotechnology, 2011, 506171.
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC3085479/Caring Sunshine. (2024). Relationship: Mitochondria and Geranylgeraniol.
URL: https://caringsunshine.com/relationships/relationship-mitochondria-and-geranylgeraniol/?srsltid=AfmBOoreg80ho5KLDRXsNb2n3IufFf7fJfZ8LSin0M5WUz6n7KvjmXjYTownsend Letter. (2025). Geranylgeraniol Boosts Endogenous Synthesis of Coenzyme Q10 and Cell Essential Metabolites, Overcoming CoQ10 Supplementation Limitations.
URL: https://townsendletter.com/geranylgeraniol-boosts-endogenous-synthesis-of-cq10-paul-et-al/Wellness Extract. (2025). Geranylgeraniol Explained: Benefits, Side Effects & Science Behind It
URL: https://wellnessextract.com/blogs/wellness/geranylgeraniol-guide?srsltid=AfmBOoousHbPD_LZ5YsghxfAred5gad0hwT8DCsxnAmag2cpahwwJ5W3Eunhee Chung, et al. (20@1). Beneficial effect of dietary geranylgeraniol on glucose homeostasis and bone microstructure in obese mice is associated with suppression of proinflammation and modification of gut microbiome. Nutr Res.
URL: https://pubmed.ncbi.nlm.nih.gov/34352722/Eunhee Chung, et al. (2021). Beneficial effect of dietary geranylgeraniol on glucose homeostasis and bone microstructure in obese mice is associated with suppression of proinflammation and modification of gut microbiome.. Nutr Res..
URL: https://pubmed.ncbi.nlm.nih.gov/34352722/Chwan-Li Shen, et al. (2022). Geranylgeraniol and Green Tea Polyphenols Mitigate Liver Inflammation and Oxidative Stress. Metabolites.
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC9610268/Muhammad Nasir Hayat Malik, et al. (2023). Geraniol Suppresses Oxidative Stress, Inflammation, and Interstitial Collagenase to Protect against Inflammatory Arthritis. AACS Omega.
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10568708/David A Hottman, et al. (2015). Protein Prenylation and Synaptic Plasticity: Implications for Alzheimer’s Disease. Mol Neurobiol..
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC4082763/Nigel C Jiwan, et al. (2022). Geranylgeraniol Supplementation Mitigates Soleus Muscle Atrophy via Changes in Mitochondrial Quality in Diabetic Rats. In Vivo.
URL: https://pubmed.ncbi.nlm.nih.gov/36309365/Chwan-Li Shen, et al. (2018). A 12-week evaluation of annatto tocotrienol supplementation for postmenopausal women: safety, quality of life, body composition, physical activity, and nutrient intake. BMC Complement Altern Med.
URL: https://pubmed.ncbi.nlm.nih.gov/29954374/Chwan-Li Shen, et al. (2016). .Safety and efficacy of tocotrienol supplementation for bone health in postmenopausal women: protocol for a dose-response double-blinded placebo-controlled randomised trial. BMJ Open, 6(11), e012447.
URL: https://pubmed.ncbi.nlm.nih.gov/28011809/Natural Health Connect AU. (2025). Dosage Guidelines for Annatto Tocotrienol and Geranylgeraniol.
URL: https://www.naturalhealthconnect.com.au/dosage-guidelinesHeart.org. (2023). Prevention and Treatment of Metabolic Syndrome.
URL: https://www.heart.org/en/health-topics/metabolic-syndrome/prevention-and-treatment-of-metabolic-syndromeMayo Clinic. (2025). Metabolic syndrome - Diagnosis & treatment.
URL: https://www.mayoclinic.org/diseases-conditions/metabolic-syndrome/diagnosis-treatment/drc-20351921
Disclaimer: This information is for educational purposes and does not constitute medical advice. Always consult with your healthcare provider before starting any new supplement regimen, particularly if you have existing health conditions or are taking medications.